Ascendiant Capital Markets, LLC

Ascendiant News

See Our Impact

Need capital to meet your growth plans? Get in touch with our team today!

Ascendiant Serves as Financial Advisor on $25,200,000 Registered Direct for Atossa Therapeutics, Inc. (NasdaqCM: ATOS)

JUPITER, Florida — January 8, 2021 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the closing of a $25,200,000 Registered Direct for Atossa Therapeutics, Inc. (NasdaqCM: ATOS) of Seattle, Washington. For a copy of the announcement, please click here.

Share this post with your friends:

Want to stay up-to-date with the latest at Ascendiant? Subscribe to our mailing list!

See other recent news

View All

July 6, 2022

Ascendiant Serves as Sole M&A Advisor on SINTX Technologies, Inc.’s (Nasdaq: SINT) Acquisition of Technology Assessment & Transfer, Inc. (TA&T)

June 27, 2022

Ascendiant Initiates Research Coverage on Blackboxstocks Inc. (Nasdaq: BLBX)

June 23, 2022

Ascendiant Capital Markets LLC serves as Sole M&A Advisor on Sale of Pinnacle Precision to The Partner Companies

June 15, 2022

Ascendiant Capital Markets LLC serves as Sole Sales Agent on $46,400,000 At-the-Market (ATM) Offering for BitNile Holdings, Inc.’s Series D Preferred Stock (NYSE American: NILE PRD)

May 31, 2022

Ascendiant Serves as Sole Placement Agent on $6,015,000 Private Placement for Nemaura Medical, Inc. (Nasdaq: NMRD), Increases Total Amount to $36,045,000 over Three Transactions

April 7, 2022

Ascendiant Serves as Financial Advisor on $50,000,000 Registered Direct for PAVmed Inc. (Nasdaq: PAVM)

April 4, 2022

Ascendiant Serves as Sole Sales Agent on $9,360,000 At-The-Market (ATM) Offering for ENDRA Life Sciences, Inc. (Nasdaq: NDRA)

March 10, 2022

Ascendiant Serves as Sole Placement Agent on $10,700,000 Private Placement for Intrusion, Inc. (Nasdaq: INTZ)

February 28, 2022

Ascendiant Serves as Sole Sales Agent on $200,000,000 At-the-Market (ATM) Offering for BitNile Holdings, Inc. (NYSE American: NILE)

January 24, 2022

Ascendiant Initiates Research Coverage on SurgePays, Inc. (Nasdaq: SURG)

January 11, 2022

Ascendiant Serves as Placement Agent on $13,700,000 Public Offering for EVmo, Inc.

December 26, 2021

Ascendiant Initiates Research Coverage on Lucid Diagnostics, Inc. (Nasdaq: LUCD)

What We Do

Ascendiant Capital Markets, LLC

Ascendiant News

See Our Impact

Ascendiant Serves as Financial Advisor on $25,200,000 Registered Direct for Atossa Therapeutics, Inc. (NasdaqCM: ATOS)

Share this post with your friends:

Want to stay up-to-date with the latest at Ascendiant? Subscribe to our mailing list!

See other recent news

Big enough to deliver

but small enough to care

Services

Resources

Quicklinks

Contact

Hi there!